Position in EDIT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$220,786
+$52,471 QoQ
Shares Held
68,144
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#77
of 216 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Joel Isaacson & Co., LLC holds $3,465,389 across 6 Biotechnology names. EDIT ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,067 | $1,912,397 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
10,247 | $802,032 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
575 | $285,619 | |
| 4 | EDIT |
Editas Medicine, Inc.
This page
|
68,144 | $220,786 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
25,000 | $218,875 | |
| 6 | CGEN |
Compugen Ltd
|
12,000 | $25,680 |
All Filings in EDIT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,786 | 68,144 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $168,315 | 68,144 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $139,695 | 68,144 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||